Economic sectors
Launch a PPP program for Pharmaceutical and Life Sciences Companies in Jordan
A free 17-page guide · The $500 trillion PPP infrastructure opportunity
What this guide is for
Your company launches a PPP program to supply, track and make medicines, medical equipment and diagnostics for the public health sector as public-private partnerships (PPPs).
The case
Life sciences companies keep public health supplied and tested
Public health systems buy, store and distribute medicines, equipment and tests every day, and much of that supply is still bought one short contract at a time. The health systems of the next fifty years will be supplied, equipped and tested by private partners under long-term contracts, and the companies that hold them will become part of the public infrastructure. This guide invites pharmaceutical and life sciences companies in Jordan to launch a PPP program, starting with the projects at home.
The guide
Supply the health systems of the $500 trillion PPP opportunity
Your company opens a dedicated PPP program, a team and a set of offers that supply, track, test and make medicines and medical equipment for the public health sector under long-term contracts, starting with Jordan’s $86 billion of projects and the $46 billion anchored in Aqaba.
01
A life sciences PPP team
A dedicated team that knows how PPPs are prepared, procured and paid follows every hospital, laboratory, health supply and research project in Jordan’s pipeline from the first market sounding, and it joins consortiums while sponsors are still choosing their medicines, equipment and diagnostics partner.
02
Medicine tracking and supply
Public hospitals and clinics need the right medicines in the right place at the right time. The company can run tracking, warehousing and cold-chain distribution for the public health sector as a PPP paid on availability and accuracy, so every pack can be traced from the factory to the patient.
03
Medical equipment supply and leasing
Public hospitals can lease imaging, laboratory and surgical equipment under long contracts that cover supply, maintenance, upgrades and replacement. The company prices each contract on whole-life cost and keeps the equipment running to agreed performance standards.
04
Local plants and public laboratories
Jordan has a large, export-oriented pharmaceutical industry. The company can build plants that make medicines and devices for public demand under long-term offtake agreements, and run public laboratories and diagnostics centers as PPPs with the same quality systems.
05
Research, direct proposals and small-scale PPPs
Jordan’s PPP Law No. 19 of 2023 accepts direct private proposals under Article 15, and PPP Regulation No. 9 of 2024 defines small-scale PPPs below $14.1 million, which can be bundled into one feasibility report and one tender. The company can propose a research or clinical trial facility with a university, or a diagnostics network, and run it as a PPP.
Why pharmaceutical and life sciences companies
Life sciences companies keep public health supplied and tested
A health PPP depends on the medicines, equipment and tests that reach each patient. Sponsors bring the equity and contractors bring the building, while pharmaceutical and life sciences companies bring the products, the quality systems and the supply chains that keep care running every day.
Where life sciences companies fit in a PPP
- Supply chain
- Medicine supply, tracking, warehousing and cold-chain distribution that follow every pack from the factory to the patient.
- Equipment
- Supply, leasing, maintenance and replacement of imaging, laboratory and surgical equipment across the life of the contract.
- Diagnostics
- Public laboratories and diagnostics centers built, equipped and run under performance standards.
- Manufacturing
- Local plants that make medicines and devices for public demand under long-term offtake agreements.
- Research
- Research and clinical trial facilities built and run with universities and public hospitals.
What changes for life sciences companies
AI, robotics and tokenization change how medicines and tests reach the public. AI forecasts demand and plans production, stock and delivery for every hospital, robots carry more of the filling, packing, dispensing and laboratory work, and digital records follow each batch from the plant to the patient. Tokenized stakes let residents and investors own part of the plants and laboratories that serve them, and live data makes each service easier to measure and pay for.
Why a program, and why now
A pharmaceutical company that waits for the next supply tender competes on price for one contract at a time. A program gives it a team, standard terms and long-term partnerships with the public health sector, and it moves the company from selling products to running services it co-owns. Jordan’s pipeline includes hospitals, clinics and other health projects, and the companies that join consortiums as they form will supply those services for decades.
Futureproofing
Futureproof Pharmaceutical and Life Sciences Companies in Jordan for the infrastructure singularity
This free 17-page guide shows how, with small PPPs in parallel, PPP research labs, artificial intelligence, robotics, tokenization and six first steps.
Jordan and Aqaba
An $86 billion pipeline to start with
The hospitals, clinics and health programs among them will need partners that can supply their medicines, equipment and diagnostics for decades. A Jordanian life sciences company that supplies one health PPP at home can carry the same model to the next one across the region.
- $86B
- of PPP and infrastructure projects in development in Jordan
- $46B
- of them anchored in Aqaba
Artificial intelligence
AI is already speeding up drug discovery, trial design and diagnosis, and a PPP extends it to the supply chain and the public laboratory. A life sciences company can use AI to forecast demand for each medicine across public hospitals, plan production and cold-chain routes, read test results faster and predict equipment failures, so it meets the performance standards a PPP pays for and prices each bid on real data.
Robotics
Robots already fill vials, pack medicines and run laboratory tests around the clock. A life sciences company can bring that automation into the plants, warehouses and laboratories of a PPP, from automated dispensing and sample handling to robotic warehouses that keep medicines at the right temperature, so a small team can serve many hospitals with fewer errors.
Tokenization
A supply, equipment or laboratory PPP earns service payments from government for years, the kind of steady cash flow a token represents well. A life sciences company can offer tokenized stakes in its PPP plants, laboratories and distribution centers to Jordanian and regional investors and the diaspora, pay holders as the payments arrive and record each batch and shipment on the same registry.
Small PPPs and research labs
Small PPPs let a life sciences company test new models of supply and testing at low risk, from AI stock forecasting and smart medicine cabinets in a few clinics to point-of-care testing and automated laboratories. A health lab inside the ministry can run these pilots across several sites, publish what works and give the company the evidence it needs before the same model reaches a national tender.
Unsolicited proposals
A life sciences company sees where medicines run short, where tests take too long and where equipment sits idle. A direct proposal lets it turn that knowledge into a project of its own design, such as a medicine tracking system or a regional diagnostics network, protect the innovation behind it and keep the right to match the best offer if the project goes to tender.
The program
How the program could work
The program can sit beside the company’s plants, laboratories and distribution business, with a PPP lead at its center and the products, quality systems and regulatory approvals the company already has behind it.
- PPP team
- A small team of commercial, regulatory, supply chain, finance and legal people that covers every health PPP in the pipeline from the first market sounding.
- Supply and tracking
- Medicine tracking, warehousing and cold-chain distribution for public hospitals and clinics, paid on availability and accuracy.
- Equipment
- Supply, leasing, maintenance and replacement of medical equipment under long contracts priced on whole-life cost.
- Diagnostics
- Public laboratories and diagnostics centers built, equipped and run as PPPs under agreed turnaround and quality standards.
- Manufacturing
- Local plants that make medicines and devices for public demand under long-term offtake agreements.
- Research
- Research and clinical trial facilities with universities, brought to government as direct proposals under Article 15 or as small-scale PPPs below $14.1 million.
- Partners
- Agreements with hospital groups, contractors, logistics operators, banks and infrastructure funds that complete each consortium.
What the company gains
The company gains long-term contracts with the public health sector, revenue tied to the service it delivers and a stake in the plants, laboratories and distribution centers it runs. Each contract builds a performance record that lenders and contracting authorities trust, which qualifies the company for larger health programs in Jordan and across the region.
It also gains a position in how health systems will be supplied. The first life sciences company in the region to run a public medicine supply chain or laboratory network with AI, robotics and live performance reporting will set the standard that later contracts are measured against.
Next steps
How a life sciences company can start
Any pharmaceutical or life sciences company in Jordan can take this guide forward. The first steps use the plants, laboratories and supply chains the company already has.
01
Mandate
Board approval for a health supply PPP program, with its products and services, the equity it can commit and its first-year goals.
02
Team
A named program lead, with commercial, regulatory, supply chain, finance and legal people drawn from the company’s existing teams.
03
Pipeline
A map of the hospitals, clinics, laboratories and health programs in Jordan’s $86 billion pipeline, and early meetings with the contracting authorities and hospital groups that will need medicines, equipment and tests.
04
Offers
Supply, equipment, diagnostics and manufacturing offers packaged for public health PPPs and priced for whole-life contracts.
05
Partners
Hospital groups, contractors, logistics operators, universities, banks and technology companies to complete each consortium.
06
Pilot
A first supply, laboratory or research project as a small-scale PPP or direct proposal, taken from idea to submission.
Jordan has the projects, a large, export-oriented pharmaceutical industry and a law that accepts unsolicited proposals. A PPP program puts your company’s medicines, equipment and tests inside the health systems of the superintelligent infrastructure future from their first day of operation.
The full document
Inside this guide
Seventeen pages and thirteen sections, from the case for a PPP program to the first steps, written for pharmaceutical and life sciences companies in Jordan.
Download the guide (PDF)
- 01IntroductionWhy a century of infrastructure needs rebuilding, and the $500 trillion it will take.p. 3
- 02The guideSupply the health systems of the $500 trillion PPP opportunityp. 5
- 03Jordan and AqabaAn $86 billion pipeline to start withp. 6
- 04Artificial intelligenceHow AI designs, structures and runs PPP projects, and what it means for pharmaceutical and life sciences companies.p. 7
- 05RoboticsHow robots build infrastructure and keep it running, and what that means for pharmaceutical and life sciences companies.p. 8
- 06TokenizationHow tokenization funds projects from their own revenue, and the role it opens for pharmaceutical and life sciences companies.p. 9
- 07Small PPPs in parallelWhy many small PPPs teach a country faster than a few large ones.p. 10
- 08PPP research labsA lab in each sector, running ten small PPP projects a year.p. 11
- 09Unsolicited proposalsHow Jordan’s PPP law accepts direct proposals from private companies.p. 12
- 10Why pharmaceutical and life sciences companiesLife sciences companies keep public health supplied and testedp. 13
- 11The programThe program can sit beside the company’s plants, laboratories and distribution business, with a PPP lead at its center and the products, quality systems and regulatory approvals the company already has behind it.p. 14
- 12AboutAbout Jordan PPP and what it offers.p. 15
- 13Next stepsHow a life sciences company can start: six first steps.p. 16
Questions
Questions about the guide for Pharmaceutical and Life Sciences Companies in Jordan
- What does the guide for Pharmaceutical and Life Sciences Companies in Jordan propose?
- Your company launches a PPP program to supply, track and make medicines, medical equipment and diagnostics for the public health sector as public-private partnerships (PPPs).
- Why should pharmaceutical and life sciences companies in Jordan launch a PPP program?
- Life sciences companies keep public health supplied and tested. A health PPP depends on the medicines, equipment and tests that reach each patient. Sponsors bring the equity and contractors bring the building, while pharmaceutical and life sciences companies bring the products, the quality systems and the supply chains that keep care running every day.
- Which PPP projects can pharmaceutical and life sciences companies in Jordan take part in?
- Jordan has about $86 billion of PPP and infrastructure projects in development, $46 billion of them anchored in Aqaba. The hospitals, clinics and health programs among them will need partners that can supply their medicines, equipment and diagnostics for decades. A Jordanian life sciences company that supplies one health PPP at home can carry the same model to the next one across the region.
- How can pharmaceutical and life sciences companies in Jordan start a PPP program?
- Any pharmaceutical or life sciences company in Jordan can take this guide forward. The first steps use the plants, laboratories and supply chains the company already has. The guide sets out six first steps: mandate, team, pipeline, offers, partners and pilot.
- What does a PPP program give pharmaceutical and life sciences companies in Jordan?
- The company gains long-term contracts with the public health sector, revenue tied to the service it delivers and a stake in the plants, laboratories and distribution centers it runs. Each contract builds a performance record that lenders and contracting authorities trust, which qualifies the company for larger health programs in Jordan and across the region.
- Is the guide for Pharmaceutical and Life Sciences Companies in Jordan free?
- Yes. It is free to read on this page and free to download as a 17-page PDF, with the case for a PPP program, Jordan’s pipeline, the role of AI, robotics and tokenization, the program and six first steps.
Guide 41 of 52
Browse all 52 guides